| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,098 | $11.75 | $12,901.50 | -6.0% | +28.8% | -21.4% | |
| Jan 10, 2022 | Christine Ring75 | General Counsel | Sale+OE | 1,200 | $27.14 | $32,568.00 | -48.3% | -46.8% | -52.9% | |
| Jan 3, 2022 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,828 | $28.96 | $52,938.88 | -11.4% | -51.1% | -63.4% | |
| Dec 10, 2021 | Christine Ring75 | General Counsel | Sale+OE | 1,200 | $29.04 | $34,848.00 | -48.3% | -51.0% | -58.2% | |
| Dec 1, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $29.13 | $11,652.00 | -2.7% | -45.3% | -57.1% | |
| Nov 10, 2021 | Christine Ring75 | General Counsel | Sale+OE | 1,200 | $32.38 | $38,856.00 | -48.3% | -42.7% | -59.0% | |
| Nov 1, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $33.24 | $13,296.00 | -2.7% | -46.0% | -61.8% | |
| Oct 27, 2021 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 400 | $35.00 | $14,000.00 | -2.7% | -42.6% | -64.0% | |
| Oct 27, 2021 | Christine Ring75 | General Counsel | Sale+OE | 800 | $35.25 | $28,200.00 | -38.4% | -42.6% | -64.0% | |
| Oct 11, 2021 | Christine Ring75 | General Counsel | Sale+OE | 1,200 | $27.36 | $32,832.00 | -48.3% | -17.0% | -60.6% |